- IN BRIEF
Hepatokine improves glucose control
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 19, 756 (2020)
doi: https://doi.org/10.1038/d41573-020-00171-4
References
Gray, M. A. et al. SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Sci. Transl Med. 12, eaaz8048 (2020)